Late last year, Pennsylvania’s first Xarelto trial concluded with a Philadelphia jury awarding $28 million to an Indiana woman who was injured by the drug. In January of this year, however, the verdict was dismissed due to insufficient evidence in relation to the substantial award. Three other Pennsylvania plaintiffs are…
Xarelto is an anticoagulant (blood thinner) used to treat certain medical conditions, such as atrial fibrillation, stroke, and deep vein thrombosis. Although this drug and others in its class are quite effective, they carry the risk of serious side effects, some which can be life-threatening. As a result, Xarelto manufacturers,…
Medical complications linked to blood-thinning medication Xarelto have been making headlines the past few years, but the most recent news reports are especially disturbing. The anticoagulant is still being prescribed, despite reports that the drug was linked to more than 15,000 adverse events in 2016. According to a recent study…
Many people assume that prescription drugs and medical devices are always tested before they hit the shelves. Unfortunately, this is not always true. In many cases, the FDA may approve a new drug if it has the same mechanism of action, form and strength as an existing drug that has…
Xarelto is a type of anticoagulant (blood thinner) medication that quickly grew in popularity following its release in 2011. For decades, warfarin had been the only reliable treatment for patients with blood-clotting disorders, such as atrial fibrillation and deep vein thrombosis. Although effective, warfarin requires regular blood monitoring. Xarelto, on…
According to a recently-released report by the news organization ProPublica, manufacturers of the anticoagulant (blood thinner) Xarelto made more physician payments than any other drug company in 2015. Physician payments were made for promotional speaking, travel, gifts, and meals. But not for research. Past studies have shown that when physicians…
Since being approved in October of 2010, the prescription blood thinning drug, Pradaxa, has established itself as an upgrade to warfarin because it performed the same functions while also preventing strokes. Other competitors to warfarin, such as Xarelto, have also come onto the market. While these drugs netted gigantic profits…
Xarelto, a blood-thinning medication, was deemed in 2011 to be a safe alternative to traditionally-used warfarin medication in preventing blood clots, which can lead to life-threatening strokes and other ailments. Despite the drug being tested and approved as safe, thousands of cases have emerged over the years that suggest the…
Xarelto is a popular anticoagulant (blood thinner) used by thousands of patients at risk of blood clots, atrial fibrillation, and stroke. Marketed as a lower-maintenance alternative to predecessor Coumadin, the relatively new drug grew quickly in popularity. Although Xarelto doesn’t require the regular patient monitoring required by Coumadin, it does…
As with any anticoagulants (blood thinners) on the market today, Xarelto increases the risk of hemorrhaging, also known as excessive bleeding. However, patients on Xarelto have more than double the risk of stomach bleeding than those on another type of blood thinner. Furthermore, there is currently no antidote to reverse…